“We’ve Got to Get This Right From the Start”: Expert Discusses MDPNP Impacts on Pharmacies
April 23rd 2025Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discussed concerns the association has with the implementation of the Medicare Drug Price Negotiation Plan
Read More
The RIVAWAR Trial and ACS Guidelines for LV Thrombus
Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial and the newest ACS guidelines.
Read More
Updates to Acute Coronary Syndrome Guidelines
Host Craig Beavers speaks with Steven Dunn about the latest ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes.
Read More
Everything You Need to Know From the American College of Cardiology 2025 Scientific Session
Host Craig Beavers spoke with several presenters, researchers, and experts about the key data being discussed at the meeting.
Read More
ACC 2025: Intravenous Iron Safe, but Results in Mixed Findings for Patients With Heart Failure
March 30th 2025Patients in the treatment group had a 21% lower risk of cardiovascular death or first heart failure hospitalization overall, but the between-group difference did not meet the threshold for statistical significance for this primary end point.
Read More
Pharmacists Are Crucial Team Members When Managing Affordability, Access to Opzelura
March 14th 2025Matthew Zirwas, MD, addresses the significant financial burden associated with the medication, emphasizing the importance of pharmacists in navigating prior authorizations and access patient support programs.
Read More